Contact this trialFirst, we need to learn more about you.
Antibody-Drug Conjugate
TH1902 for Cancer
Recruiting1 awardPhase 1
Gettysburg, Pennsylvania
This trial is testing a new drug, TH1902, in cancer patients who have few other treatment options. The first part of the trial is to find the best dose of the drug, and the second part is to test it in patients with specific types of cancer that are known to express a protein called SORT1.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.